ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

NVRO Nevro Corp

9.35
0.18 (1.96%)
May 31 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 402,774
Bid Price
Ask Price
News -
Day High 9.4299

Low
8.93

52 Week Range

High
28.42

Day Low 9.15
Share Name Share Symbol Market Stock Type
Nevro Corp NVRO NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
0.18 1.96% 9.35 15:51:41
Open Price Low Price High Price Close Price Previous Close
9.30 9.15 9.4299 9.35 9.17
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
5,912 402,774 US$ 9.28 US$ 3,738,401 - 8.93 - 28.42
Last Trade Type Quantity Price Currency
18:00:00 99,828 US$ 9.35 USD

Nevro (NVRO) Options Flow Summary

Overall Flow

Bearish

Net Premium

-4M

Calls / Puts

0.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

Nevro Corp Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
340.32M 36.40M - 425.17M -92.21M -2.53 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Nevro News

Date Time Source News Article
5/30/202416:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/30/202416:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/30/202416:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/29/202415:21Edgar (US Regulatory)Form 8-K - Current report
5/28/202417:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/28/202417:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/28/202417:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/24/202415:15PR Newswire (US)Nevro Announces New Employee Inducement Grants Under NYSE..
5/17/202415:40Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of..
5/09/202415:52Edgar (US Regulatory)Form 8-K - Current report
5/09/202415:05PR Newswire (US)Nevro to Present at BofA Securities 2024 Healthcare..
5/07/202415:56Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NVRO Message Board. Create One! See More Posts on NVRO Message Board See More Message Board Posts

Historical NVRO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week9.449.569.139.30565,771-0.09-0.95%
1 Month11.4511.798.9310.21592,982-2.10-18.34%
3 Months15.1315.988.9311.80526,551-5.78-38.20%
6 Months16.9322.648.9315.46551,239-7.58-44.77%
1 Year26.6028.428.9317.93548,300-17.25-64.85%
3 Years150.00182.458.9350.95552,560-140.65-93.77%
5 Years58.64188.148.9374.60491,211-49.29-84.06%

Nevro Description

Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany.